Skip to main content
. 2015 Apr 17;5(8):796–804. doi: 10.7150/thno.11220

Figure 6.

Figure 6

Theranostic on-chip imaging. BTK-positive Rec-1 cells or BTK-negative Jurkat T-cell leukemia cells using fluorescent BTK inhibitor (Ibrutinib-BFL), anti-CD20-APC, and Hoechst stain. Note the high drug uptake and binding in Rec-1 cells. Scale bar: 5 µm.